Table 3:

Patients selected for decolonization

Variable	Not Prescribed Decolonization	Prescribed Decolonization	p value
	n=280 (%)	n=119 (%)
Risk Factors
Immunocompromised	10 (3.6%)	4 (3.4%)	0.99
Cardiac Disorder	12 (4.3%)	2 (1.7%)	0.25
Attend Day Care	58 (20.7%)	24 (20.2%)	0.96
Prior Hx of abscess/cellulitis	47 (16.8%)	38 (31.9%)	0.002
Prior Hx of MRSA	13 (4.6%)	21 (17.6%)	0.0001
# of family members with Hx of abscess/cellulitis (mean ± SD)	0.20 ± 0.55	0.47 ± 0.75	<0.0001
# of family members with Hx MRSA (mean ± SD)	0.05 ± 0.25	0.27 ± 0.63	<0.0001
Previous hospitalization that year	37 (6.1%)	20 (16.8%)	0.35
Community-acquired MRSA	263 (94.0%)	114 (95.8%)	0.63
Hospital-acquired MRSA	17 (6.1%)	5 (4.2%)
Indwelling catheter or device	1 (0.4%)	0	0.99
Clinical Factors and Outcomes
Duration of symptoms prior to presentation (mean ± SD, days)	4.25 ± 6.34	4.73 ± 4.26	0.01
Size of abscess (mean ± SD; cm)	4.35 ± 3.10	4.32 ± 2.66	0.57
Fever	117 (41.8%)	37 (31.1%)	0.09
Leukocytosis	139 (81.3%)	52 (91.2%)	0.98
Nasal MRSA Screen	19 (6.8%)	8 (6.7%)	0.99
Antibiotics administered			0.38
None	0	1 (0. 8%)
PO antibiotics only	13 (4.6%)	3 (2.5%)
IV antibiotics only	151 (54.1%)	64 (53.8%)
Both PO and IV antibiotics	115 (41.2%)	51 (42.9%)
Length of Stay (mean ± SD, days)	75.78 ± 79.77	53.45 ± 33.09	0.01